3098 Nivolumab (NIVO) monotherapy or in combination with ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC)


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Calvo, E; López-Martin, JA; Bendell, J; Eder, JP; Taylor, M; Ott, PA; Pietanza, MC; Horn, L; Jäger, D; Braud, FD; Morse, MA; Ascierto, PA; Le, DT; Amin, A; Evans, J; Simon, J; Lin, CS; Christensen, O; Antonia, SJ

Published Date

  • September 2015

Published In

Volume / Issue

  • 51 /

Start / End Page

  • S633 - S633

Published By

International Standard Serial Number (ISSN)

  • 0959-8049

Digital Object Identifier (DOI)

  • 10.1016/s0959-8049(16)31739-7